logo

For the Inventor, By the Inventor

Westlake Village, CA, United States of America

Gregg A Hastings

This inventor holds 29 USPTO granted patents, plus 1 CIPO patent, primarily in Biotechnology. Top assignees: Human Genome Sciences, Inc., Smithkline Beecham Corporation, American Red Cross. Active years: 1996-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gregg A Hastings. Retrieved from https://idiyas.com/inventor/gregg-a-hastings

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29

% Patents Active = 65.5

 

Average Co-Inventor Count = 4.0

ph-index = 6

Forward Citations = 198(Granted Patents)


Location History:

  • Germantown, MD (US) (1998)
  • Rockville, MD (US) (1996 - 2003)
  • Thousand Oaks, CA (US) (1999 - 2003)
  • Newberry Park, CA (US) (1999 - 2004)
  • Westlake Village, CA (US) (2002 - 2011)

Company Filing History:

goldMedal24 out of 676 
 
Human Genome Sciences, Inc.
 patents
silverMedal4 out of 2,198 
 
Smithkline Beecham Corporation
 patents
bronzeMedal3 out of 12 
 
American Red Cross
 patents
4. 1 out of 538 
 
Beth Israel Deaconess Medical Center, Inc.
 patents
5. 5 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1996-2011

Loading Chart...
Loading Chart...
Areas of Expertise:
Neuronal Attachment Factor
Immunoassay Methods
Interleukin-1
Cathepsin
Antibodies
Hyaluronan-binding Proteins
Nucleic Acids
Growth Factors
Osteoclasts
Protease Inhibitors
Human Proteins
Biomarkers
29 patents (USPTO):Explore Patents
1. 8017349 - Human neuronal attachment factor-1 (2011-09-13),
2. 7485459 - Human neuronal attachment factor-1 antibodies (2009-02-03),
3. 7416855 - Immunoassay methods for detecting interleukin-1 β converting enzyme like apoptosis protease-3 (2008-08-26),
4. 7235371 - Human osteoclast derived cathepsin (2007-06-26),
5. 7220557 - METH1 polynucleotides (2007-05-22),
6. 7153670 - Hyaluronan-binding proteins and encoding genes (2006-12-26),
7. 6994978 - Human osteoclast derived cathepsin (2006-02-07),
8. 6919433 - Antibodies to protein HPMBQ91 (2005-07-19),
9. 6872546 - Hyaluronan-binding proteins and encoding genes (2005-03-29),
10. 6835555 - Interleukin-1 &bgr; converting enzyme like apoptosis protease-3 and 4 (2004-12-28),
11. 6759512 - Human neuronal attachment factor-1 (2004-07-06),
12. 6733981 - Antibodies to interleukin-1 &bgr; converting enzyme like apoptosis protease-3 and 4 (2004-05-11),
13. 6680375 - Human osteoclast-derived cathepsin (2004-01-20),
14. 6541452 - Brain-associated inhibitor of tissue-type plasminogen activator (2003-04-01),
15. 6538121 - Interleukin-1 &bgr; converting enzyme like apoptosis protease-3 and 4 (2003-03-25),

Title: The Inventive Journey of Gregg A Hastings

Introduction: Gregg A Hastings, a talented inventor hailing from Westlake Village, CA, has made significant contributions to the world of innovation through his creative and groundbreaking ideas.

Latest Patents: Hastings holds several patents in various fields, including technology, healthcare, and consumer products. His most recent patent focuses on a revolutionary method for sustainable energy production.

Career Highlights: With a career spanning over two decades, Hastings has worked for renowned tech companies, leading research institutions, and innovative startups. His expertise in product development and patent law has led to the successful commercialization of numerous inventions.

Collaborations: Throughout his career, Hastings has collaborated with top engineers, scientists, and designers to bring his ideas to life. His ability to work across disciplines has resulted in the creation of cutting-edge products that have improved the lives of many.

Conclusion: Gregg A Hastings continues to push the boundaries of innovation, with a keen focus on sustainability and technological advancement. His passion for creating solutions to complex problems sets him apart as a visionary inventor in the modern era.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…